1. Home
  2. RAPT vs MGYR Comparison

RAPT vs MGYR Comparison

Compare RAPT & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • MGYR
  • Stock Information
  • Founded
  • RAPT 2015
  • MGYR 1922
  • Country
  • RAPT United States
  • MGYR United States
  • Employees
  • RAPT N/A
  • MGYR N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • MGYR Savings Institutions
  • Sector
  • RAPT Health Care
  • MGYR Finance
  • Exchange
  • RAPT Nasdaq
  • MGYR Nasdaq
  • Market Cap
  • RAPT 117.5M
  • MGYR 94.1M
  • IPO Year
  • RAPT 2019
  • MGYR 2006
  • Fundamental
  • Price
  • RAPT $0.79
  • MGYR $13.95
  • Analyst Decision
  • RAPT Hold
  • MGYR
  • Analyst Count
  • RAPT 7
  • MGYR 0
  • Target Price
  • RAPT $5.00
  • MGYR N/A
  • AVG Volume (30 Days)
  • RAPT 1.1M
  • MGYR 2.5K
  • Earning Date
  • RAPT 05-08-2025
  • MGYR 04-29-2025
  • Dividend Yield
  • RAPT N/A
  • MGYR 1.82%
  • EPS Growth
  • RAPT N/A
  • MGYR 10.61
  • EPS
  • RAPT N/A
  • MGYR 1.30
  • Revenue
  • RAPT N/A
  • MGYR $32,424,000.00
  • Revenue This Year
  • RAPT N/A
  • MGYR N/A
  • Revenue Next Year
  • RAPT N/A
  • MGYR N/A
  • P/E Ratio
  • RAPT N/A
  • MGYR $10.70
  • Revenue Growth
  • RAPT N/A
  • MGYR 7.24
  • 52 Week Low
  • RAPT $0.79
  • MGYR $10.66
  • 52 Week High
  • RAPT $8.58
  • MGYR $14.90
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 31.31
  • MGYR 48.87
  • Support Level
  • RAPT $0.81
  • MGYR $13.52
  • Resistance Level
  • RAPT $0.98
  • MGYR $13.84
  • Average True Range (ATR)
  • RAPT 0.10
  • MGYR 0.11
  • MACD
  • RAPT -0.03
  • MGYR 0.02
  • Stochastic Oscillator
  • RAPT 7.72
  • MGYR 68.25

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.

Share on Social Networks: